The choice of a tocolytic for the treatment of preterm labor: A critical evaluation of nifedipine versus atosiban

Expert Opinion on Investigational Drugs

Volumn 16, Issue 6, 2007, Pages 843-853

  Lyndrup, Jens ^a   Lamont, Ronald F ^b  

^a ROSKILDE HOSPITAL   (Denmark)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atosiban; Ca2+ channel blockers; Labor; Nifedipine; Oxytocin; Premature; Preterm; Receptor antagonists; Tocolytics; Vasopresin

Indexed keywords

ATOSIBAN; FENOTEROL; GLUCOCORTICOID; HEXOPRENALINE; ISOPRENALINE; ISOXSUPRINE; NIFEDIPINE; PROGESTERONE; RITODRINE; SALBUTAMOL; TERBUTALINE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG INHIBITION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYNAMOMETRY; EXTREMELY LOW BIRTH WEIGHT; FETUS DEATH; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART PALPITATION; HUMAN; HYPOTENSION; HYPOXIA; INFANT MORTALITY; INTRACYTOPLASMIC SPERM INJECTION; LUNG EDEMA; MAINTENANCE THERAPY; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PREMATURE LABOR; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; TACHYCARDIA; TOCOLYSIS; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CERCLAGE; UTERUS CONTRACTION; VASODILATATION;

ADRENERGIC BETA-AGONISTS; CALCIUM CHANNEL BLOCKERS; FEMALE; HUMANS; NIFEDIPINE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RECEPTORS, OXYTOCIN; RECEPTORS, VASOPRESSIN; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 34250029856     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.16.6.843     Document Type: Review

References (72)

1. SPELLACY WN, CRUZ AC, BIRK SA et al.: Treatment of premature labor with ritodrine: a randomized controlled study. Obstet. Gynecol. (1979) 54:220-223.
2. BESINGER R, IANNUCCI TA: Tocolytic therapy. In: Preterm Labor. Elder MG, Lamont RF, Romero R (Eds), Churchill Livingston, New York, USA (1997):243-297.
3. THE CANADIAN PRETERM LABOUR INVESTIGATOR GROUP: Treatment of preterm labor with the β-adrenergic agonist ritodrine. N. Engl. J. Med. (1992) 327:308-312.
4. LEVENO KJ, CUNNINGHAM FG: β-Adrenergic agonists for preterm labor. N. Engl. J. Med. (1992) 327:349-351.
5. FILICORI M, COGNIGNI GE, GAMBERINI E, TROILO E, PERMEGIANI L, BERNARDI S: Impact of medically assisted fertility on preterm birth. BJOG (2005) 112(Suppl. 1):113-117.
6. FINNSTROM O, OLAUSSON PO, SEDIN G et al.: The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatr. (1997) 86:503-511.
7. DI RENZO GC, AL-SALEH E, MATTEI A, KOUTRAS I, CLERICI G. Use of tocolytics: what is the benefit of gaining 48 hours for the fetus? BJOG (2006) 113(Suppl. 3):72-77.
8. MAGOWAN BA, BAIN M, JUSZCZAK E et al.: Neonatal mortality amongst Scottish preterm singleton births (1985-1994). BJOG (1998) 105:1005-1010.
9. National Institutes of Health Consensus Development Conference Statement: effect of corticosteroids for fetal maturation on perinatal outcomes. Am. J. Obstet. Gynecol. (1995) 173:246-252.
10. KEIRSE MJ: The history of tocolytics. BJOG (2003) 110(S20):94-97.
11. VALENZUELA GJ, SANCHEZ-RAMOS L, ROMERO R et al.: Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am. J. Obstet. Gynecol. (2000) 182:1184-1190.
12. HOLLEBOOM CA, MERKUS JM, VAN EFFEREN LM, KEIRSE MJ: Double blind evaluation of ritodrine sustained release for oral maintenance of tocolysis after active preterm labour. BJOG (1996) 103:702-705.
13. MATIJEVIC R, GRGIC O, VASILJ O: Ritodrine in oral maintenance of tocolysis after active preterm labor: randomised controlled trial. Croat. Med. J. (2006) 47:25-31.
14. THORNTON JG: Maintenance tocolysis. BJOG (2005) 112(Suppl. 1):118-121.
15. MOUTQUIN JM, CABROL D, FISK NM et al.: Effectiveness and safety of the oxytocin antagonist atosiban versus β-adrenergic agonists in the treatment of preterm tabour. Worldwide comparative study atosiban v β-agonists. BJOG (2001) 108:133-142.
16. LAMONT RF, DUNLOP PD, CROWLEY P et al.: Comparative mortality and morbidity of infants transferred in utero or postnatally. J. Perinat. Med. (1983) 11:200-203.
17. DOWNEY LJ, MARTIN AJ: Ritodrine in the treatment of preterm labour: a study of 213 patients. BJOG (1983) 90:1046-1053.
18. LAMONT RF: The pathophysiology of pulmonary oedema with use of β-agonists. BJOG (2000) 107:439-444.
19. ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS: β-Agonists for the Care of Women in Labour. Guideline no. 1. RCOG Press, London, UK (1997).
20. ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS: Tocolytic Drugs for Women in Preterm Labour. Clinical guideline no. 1[B]. RCOG Press, London, UK (2002).
21. LAMONT RF: The development and introduction of anti-oxytocic tocolytics. BJOG (2003) 110(Suppl. 20):108-112.
22. AKERLUND M, STROMBERG P, HAUKSSON A et al.: Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. BJOG (1987) 94:1040-1044.
23. ANDERSON L-F, LYNDRUP J, AKERLUND M, MERLIN P: Oxytocin receptor blockade: a new principle in the treatment of preterm labour. Am. J. Perinatol. (1989) 6:196-199.
24. GOODWIN TM, PAUL RP, SILVER H et al.: The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am. J. Obstet. Gynecol. (1994) 170:474-478.
25. GOODWIN TM, VALENZUELA GJ, SILVER H AND THE ATOSIBAN STUDY GROUP: Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor. Obstet. Gynecol. (1996) 88:331-336.
26. GOODWIN TM, VALENZUELA GJ, SILVER H et al.: Treatment of preterm labor with the oxytocin antagonist atosiban. Am. J. Perinat. (1996) 13:143-146.
27. ROMERO R, SIBAL BM, SANCHEZ-RAMOS L et al.: An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolyric rescue. Am. J. Obstet. Gynecol. (2000) 182:1173-1183.
28. LAMONT RF, JAGGAT A: Emerging drug therapies for prevention of spontaneous preterm labour and preterm birth. Expert Opin. Invest. Drugs (2007) 16(3):337-345.
29. MARŠÁL K, FISK NM, CALDER AA et al.: The oxytocin antagonist atosiban versus the β-agonist terbutaline in the treatment of preterm labor. Acta Obstet. Gynecol. Scand. (2001) 80:413-422.
30. CABROL D, GILLET JY, MADELENAT P et al.: Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur. J. Obstet. Gynecol. (2001) 98:77-85.
31. MOUTQUIN J-M, SHERMAN D, COHEN H et al.: Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicentre effectiveness and safety study. Am. J. Obster. Gynecol. (2000) 182:1191-1199.
32. HUSSLEIN P, QUARTAROLO J-P: Review of clinical experience with atosiban and the Tractocile Efficacy Assessment Survey in Europe (TREASURE) study protocol. Int. J. Clin. Pract. (2003) 57:121-127.
33. LOCCI M, NAZZANO G, MERENDA A et al.: Atosiban versus ritodrine used prophylactically with cerclage in ICSI pregnancies to prevent preterm birth in women identified as being at high risk on the basis of transvaginal ultrasound scan. J. Obstet. Gynaecol. (2006) 26:396-401.
34. OEI SG, MOL BW, DE KLEINE MJ, BROLMANN HA: Nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet. Gynecol. Scand. (1999) 78:783-788.
35. TSATSIRIS V, PAPATSONIS D, GOFFINET F, DECKER G, CARBONNE B: Tocolysis with nifedipine or β-adrenergic agonists: a meta-analysis. Obstet. Gynecol. (2001) 97(2):840-847.
36. KING JF, FLENADY VJ, PAPATSONIS DN et al.: Calcium channel blockers for inhibiting preterm labour. Cochrane Database Syst. Rev. (2003) 1:1-50 (CD002255).
37. KING JF, FLENADY VJ, PAPATSONIS DN et al.: Calcium channel blockers for inhibiting preterm labour; a systematic review of the evidence and a protocol for administration of nifedipme. Aust. N. Z. J. Obstet. Gynaecol. (2003) 43:192-198.
38. KOKS AM, BRÖLMANN HAM, DE KLEINE M, MANGER PA: A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. Eur. J. Obstet. Gynecol. Reprod. Biol. (1998) 77:171-176.
39. LARMON JE, ROSS BS, MAY WL: Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. Am. J. Obstet. Gynecol. (1999) 181:1432-1437.
40. WEERAKUL W, CHITTACHAROEN A, SUTHUTVORAVUT S: Nifedipine versus terbutaline in the management of preterm labor. Int. J. Gynaecol. Obstet. (2002) 76:311-313.
41. PAPATSONIS DNM, VAN GEIJN HP, ADÈR HJ, LANGE FM, BLEKERE OP, DEKKER GA: Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial. Obstet. Gynecol. (1997) 90:23-34.
42. TSATSIRIS V, CARBONNE B, PAPATSONIS D, GOFFINET F: Comment on: nifedipine versus ritodrine for suppression of preterm labor; a meta-analysis. Acta Obstet. Gynecol. Scand. (2000) 79:618-619.
43. LAMONT RF, KHAN KS, BEATTIE B et al.: The quality of nifedipine studies used to assess tocolytic efficacy: a systematic review. J. Perinat. Med. (2005) 33:287-295.
44. BAL L, THIERRY S, BROCAS E et al.: Pulmonary edema induced by calcium channel blockade for tocolysis. Anesth. Analg. (2004) 99:910-911.
45. VAAST P, DUBREUCQ-FOSSAERT S, HOUFFLIN-DEBARGE V et al.: Acute pulmonary oedema during nicardipine therapy for premature labour: report of five cases. Eur. J. Obstet. Gynecol. Reprod. Biol. (2004) 113:98-99.
46. OEI SG, OEI SK, BRÖLMANN HAM: Myocardial infarction during nifedipine therapy for preterm labor. N. Engl. J. Med. (1999) 340:154-155.
47. VERHAERT D, VAN ACKER R: Acute myocardial infarction during pregnancy. Acta Cardiol. (2004) 59:331-339.
48. VAN VEEN AJ, PELINCK MJ, VAN PAMPUS MG, ERVIICH JJ: Severe hypotension and fetal death due to tocolysis with nifedipine. BJOG (2005) 112:509-510.
49. HODGES R, BARKEHALL-THOMAS A, TIPPETT C: Maternal hypoxia associated with nifedipine for threatened preterm labour. BJOG (2004) 111:380-381.
50. PARASURAMAN R, GANDHI MM, LIVERSEDGE NH: Nifedipine tocolysis associated atrial fibrillation responds to DC carioversion. BJOG (2006) 113:844-845.
51. SCHOLTZ H: Pharmacological aspects of calcium channel blockers. Cardiovasc. Drugs Ther. (1997) 10(3):869-872.
52. PAPATSONIS D, FLENADY V, COLE S, LILEY H: Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst. Rev. (2005) 3:CD004452.
53. AKERLUND M: Targeting the oxytocin receptor to relax the myometrium. Expert Opin. Ther. Targets (2006) 10(3):423-427.
54. HEINONEN S: Critical evaluation of evidence: a lesson to learn from a recent meta-analysis. Acta Obstet. Gynecol. Scand. (2006) 85:260-262.
55. RICHTER ON, DORN C, VAN DE VONDEL P, ULRICH U, SCHMOLLING J: Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch. Gynecol. Obstet. (2005) 272:26-30.
56. GREIG PC, MASSMAN GA, DEMAREST KT, WEGLEIN RC, HOLLAND ML, FIGUEROA JP: Maternal and fetal cardiovascular effects and placental transfer of the oxytocin antagonist atosiban in late gestation pregnant sheep. Am. J. Obstet. Gynecol (1993) 169:897-902.
57. COOMARASAMY A, KNOX EM, GEE H et al.: Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour: a meta-analysis with an indirect comparison of randomized trials. BJOG (2003) 110:1045-1049.
58. KASHANIAN M, AKBARIAN AR, SOLTANZADEH M: Atosiban and nifedipine for the treatment of preterm, labor. Int. J. Gynaecol. Obstet. (2005) 91:10-14.
59. AL-OMARI WR, AL-SHAMMAA, AL-TIKRITI EM, AHMED KW: Atosiban and nifedipine in acute tocolysis: a comparative study. Eur. J. Obstet. Gynecol. Reprod. Biol. (2006) 128:129-134.
60. PAPATSONIS DN, VAN GEIJN HP, DEKKER GA: Management of preterm labour. Nifedipine in management of preterm labour is safe. Br. Med. J. (1999) 319:257.
61. PAPATSONIS DN, KOK JH, VAN GEIJN HP, BLEKER OP, ADER HJ, DEKKER GA: Neonatal effects of nifedipine and ritodrine for preterm labor. Obstet. Gynecol. (2000) 95:477-481.
62. PAPATSONIS DN, VAN GEIJN HP, DEKKER GA: Nifedipine as a safe and effective tocolytic agent in the treatment of preterm labour. Am. J. Obstet. Gynecol. (2000) 183:513-514.
63. PAPATSONIS DN, LOK CA, BOS JM, VAN GEIJN HP, DEKKER GA: Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. (2001) 97:122-140.
64. PAPATSONIS DN, TIMMERMAN CC, OEI SG, VAN GEIJN HP: Nifedipine first choice in management of threatening preterm labor. Ned. Tijdschr. Geneeskd (2002) 146:1980-1983.
65. PAPATSONIS DN, VAN GEIJN HP, BLEKER OP, ADER HJ, DEKKER GA: Hemodynamic and metabolic effects after nifedipine and ritodrine tocolysis. Int. J. Gynaecol. Obstet. (2003) 82:5-10.
66. MITTENDORF R, PRYDE PG: A review of the role for magnesium sulphate in preterm labour. BJOG (2005) 112(1):84-88.
67. GRIMES DA, NANDA K: Magnesium sulfate tocolysis: time to quit. Obstet. Gynecol. (2006) 108:986-989.
68. KEIRSE MJ: New perspectives for the effective treatment of preterm labor. Am. J. Obstet. Gynecol. (1995) 173:618-628.
69. PETROU S: Economic consequences of preterm birth and low birthweight. BJOG (2003) 110(Suppl. 20):17-23.
70. GILBERT WM, NESBITT TS, DANIELSEN B: The cost of prematurity: quantification by gestational age and birth weight. Obstet. Gynecol. (2003) 102:488-493.
71. KOS M, WERTHEIMER AI, MRHAR A: Satisfaction with pharmacotherapy for approved and off-label indications - a Delphi study. Ann. Pharmacother. (2005) 39:649-654.
72. THORNTON J: The drugs we deserve. BJOG (2003) 110:969-970.